Division of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Division of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Surg Clin North Am. 2019 Apr;99(2):337-355. doi: 10.1016/j.suc.2018.12.008.
Gallbladder cancer (GBC) is an often lethal disease, but surgical resection is potentially curative. Symptoms may be misdiagnosed as biliary colic; over half of new diagnoses are made after laparoscopic cholecystectomy for presumed benign disease. Gallbladder polyps >1 cm should prompt additional imaging and cholecystectomy. For GBC diagnosed after cholecystectomy, tumors T1b and greater necessitate radical cholecystectomy. Radical cholecystectomy includes staging laparoscopy, hepatic resection, and locoregional lymph node clearance to achieve R0 resection. Patients with locally advanced disease (T3 or T4), hepatic-sided T2 tumors, node positivity, or R1 resection may benefit from adjuvant chemotherapy. Chemotherapy increases survival in unresectable disease.
胆囊癌(GBC)是一种通常致命的疾病,但手术切除有潜在的治愈可能。症状可能被误诊为胆绞痛;超过一半的新诊断是在腹腔镜胆囊切除术后做出的,此前认为是良性疾病。胆囊息肉>1cm 应提示进一步进行影像学检查和胆囊切除术。对于在胆囊切除术后诊断出的胆囊癌,T1b 及更高级别的肿瘤需要根治性胆囊切除术。根治性胆囊切除术包括分期腹腔镜检查、肝切除术和局部淋巴结清扫术,以实现 R0 切除。局部晚期疾病(T3 或 T4)、肝侧 T2 肿瘤、淋巴结阳性或 R1 切除的患者可能受益于辅助化疗。化疗可增加不可切除疾病的生存率。